Could a mouth rinse spot hidden HPV cancers in men?
NCT ID NCT02897427
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is looking for better ways to find HPV-related throat and anal cancers early in men. Researchers are testing whether a blood test or a simple mouth rinse can spot signs of the virus that might lead to cancer. They plan to follow 1,500 men over time to see if these tests can catch cancers sooner than current methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple blood or mouth rinse test to catch HPV-related cancers in men at an early, more treatable stage.
- What could go wrong
- This is an early screening study, not a treatment trial. It may not prove that screening reduces cancer deaths, and false positives could cause unnecessary worry or procedures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMAVIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor College of Medicine
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Better swab, better catch: study aims to sharpen anal cancer screening
- HPV vaccine trial aims to protect women with HIV from cervical cancer
- New strategies help more teens get HPV vaccine
- Education boosts HPV vaccine willingness in women, study hopes
- New study aims to get more latino teens the HPV vaccine
- New Same-Day test could transform cervical cancer screening in Low-Resource areas